Humanized Mouse Model as a Translational Tool for Immunotherapy in Oncology

Time: 11:45 am
day: Preclinical Track - Day 1 am


  • Engineering human target in huPBMC GvHD model to construct a clinic translational model
  • Deepen understanding of tumor biology and therapeutic response of multiple specific Nanobodies
  • Donor selection and HLA match for improving treatment response